Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$117.13 - $176.59 $187,408 - $282,544
-1,600 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$126.46 - $235.05 $202,336 - $376,080
1,600 New
1,600 $276,000
Q4 2021

Jan 13, 2022

SELL
$225.82 - $368.51 $135,492 - $221,106
-600 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$221.9 - $484.47 $133,140 - $290,682
600 New
600 $231,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Grassi Investment Management Portfolio

Follow Grassi Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Grassi Investment Management with notifications on news.